Para preguntas en general por favor contacte a nuestro Servicio de Atención al Cliente:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Teléfono: +49 6151 72-0
Fax: +49 6151 72 2000
15 febrero 2012
cargando
Mixture of cytotoxic glycopeptides that inhibits DNA synthesis by reacting with DNA and causing strand scission. Acts by generating hydroxyl free radicals which cleave N-glycosidic bonds and cause base elimination (mainly T) and phosphodiester bond scission. An anti-neoplastic agent. Bleomycin has been used in the treatment of squamous cell carcinomas, testicular tumors, and malignant lymphomas.
| Información sobre producto | |||
|---|---|---|---|
| Form | White to off-white solid | ||
| Hygrocopic | Si | ||
| Biological activity | Potency: 1.5-2.0 U/mg | ||
| Purity | ≥90% by HPLC (A2 + B2) | ||
| RTECS | EC5991990 | ||
| Número CAS | 9041-93-4 | ||
| Merck USA index | 14, 1318 | ||
| Almacenar y enviar información | |||
|---|---|---|---|
| Categoría de alamacenamiento | +2°C to +8°C | ||
| Ship |
Ambient Temperature Only
Harmful & Carcinogenic / Teratogenic |
||
| Información de seguridad | |||
|---|---|---|---|
| Frase S |
S: 22-26-36/37/39-45 |
||
| Frase R |
R: 20/21/22-36/37/38-40-42/43 |
||
